[Stroke: from blow of fate to treatable emergency].
Schulz-Hanke
Ines
I
D000368:Aged; D002986:Clinical Trials as Topic; D004630:Emergencies; D004921:Erythropoietin / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005858:Germany; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data*; D015337:Multicenter Studies as Topic; D010919:Placebos; D010960:Plasminogen Activators / Q000627:therapeutic use; D020521:Stroke / Q000401:mortality / Q000628:therapy*; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D010919:Placebos; D004921:Erythropoietin; D010960:Plasminogen Activators